Congenital deficiency of FXIII is an extremely rare disorder and acquired FXIII deficiency is even rarer. Patients who receive replacement factors live a normal life span. There are no large-scale studies to determine the rate of mortality. Intracranial hemorrhage is the most common cause of death in untreated patients.